Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man

E. M. Wallace; FCW Wu

doi:10.1016/0010-7824(90)90127-H

Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man

E. M. Wallace, FCW Wu

Research output: Contribution to journal › Article › Research › peer-review

20 Citations (Scopus)

Abstract

Ten normal men were given three monthly intramuscular injections of 200mg of depot medroxyprogesterone acetate (DMPA) and 250mg of testosterone oenanthate (TE) as part of a male contraceptive trial. During the three months of treatment, serum high density lipoprotein cholesterol (HDL-C) and the HDL-C:LDL-C (low density lipoprotein cholesterol) ratio were significantly depressed compared to baseline. Although the long-term effect of this alteration in lipoprotein cholesterol metabolism in normolipidaemic men is currently uncertain, these results suggest that the potential cardiovascular risks of progestagen-containing regimens for male contraception will have to be seriously considered.

Original language	English
Pages (from-to)	63-71
Number of pages	9
Journal	Contraception
Volume	41
Issue number	1
DOIs	https://doi.org/10.1016/0010-7824(90)90127-H
Publication status	Published - Jan 1990
Externally published	Yes

Access to Document

10.1016/0010-7824(90)90127-H

Cite this

@article{b7b15a89c3414dbe953277d9891fd692,

title = "Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man",

abstract = "Ten normal men were given three monthly intramuscular injections of 200mg of depot medroxyprogesterone acetate (DMPA) and 250mg of testosterone oenanthate (TE) as part of a male contraceptive trial. During the three months of treatment, serum high density lipoprotein cholesterol (HDL-C) and the HDL-C:LDL-C (low density lipoprotein cholesterol) ratio were significantly depressed compared to baseline. Although the long-term effect of this alteration in lipoprotein cholesterol metabolism in normolipidaemic men is currently uncertain, these results suggest that the potential cardiovascular risks of progestagen-containing regimens for male contraception will have to be seriously considered.",

author = "Wallace, {E. M.} and FCW Wu",

year = "1990",

month = jan,

doi = "10.1016/0010-7824(90)90127-H",

language = "English",

volume = "41",

pages = "63--71",

journal = "Contraception",

issn = "0010-7824",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man

AU - Wallace, E. M.

AU - Wu, FCW

PY - 1990/1

Y1 - 1990/1

N2 - Ten normal men were given three monthly intramuscular injections of 200mg of depot medroxyprogesterone acetate (DMPA) and 250mg of testosterone oenanthate (TE) as part of a male contraceptive trial. During the three months of treatment, serum high density lipoprotein cholesterol (HDL-C) and the HDL-C:LDL-C (low density lipoprotein cholesterol) ratio were significantly depressed compared to baseline. Although the long-term effect of this alteration in lipoprotein cholesterol metabolism in normolipidaemic men is currently uncertain, these results suggest that the potential cardiovascular risks of progestagen-containing regimens for male contraception will have to be seriously considered.

AB - Ten normal men were given three monthly intramuscular injections of 200mg of depot medroxyprogesterone acetate (DMPA) and 250mg of testosterone oenanthate (TE) as part of a male contraceptive trial. During the three months of treatment, serum high density lipoprotein cholesterol (HDL-C) and the HDL-C:LDL-C (low density lipoprotein cholesterol) ratio were significantly depressed compared to baseline. Although the long-term effect of this alteration in lipoprotein cholesterol metabolism in normolipidaemic men is currently uncertain, these results suggest that the potential cardiovascular risks of progestagen-containing regimens for male contraception will have to be seriously considered.

UR - http://www.scopus.com/inward/record.url?scp=0025021154&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(90)90127-H

DO - 10.1016/0010-7824(90)90127-H

M3 - Article

C2 - 2137405

AN - SCOPUS:0025021154

VL - 41

SP - 63

EP - 71

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 1

ER -

Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man

Abstract

Access to Document

Other files and links

Cite this